Frequently Asked Questions
The Point of Care Infectious Disease Market size will be worth USD 29.56 billion by 2031 during the forecast period.
The Point of Care Infectious Disease Market growth rate is 7.2% during the forecast period.
The Growing Prevalence of Infectious Diseases and Government Initiatives for Accessible Treatment are the growth drivers of the Point of Care Infectious Disease Market.
The technological offering, clinical application, disease, and end users are the factors on which the Point of Care Infectious Disease Market research is based.
The major companies in the Point of Care Infectious Disease Market are Abbott (U.S.), Abaxis (U.S.), PTS Diagnostics (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Samsung Medison Co., Ltd. (South Korea), Bio-Rad Laboratories, Inc. (U.S.), The Menarini Group (Italy), Nova Biomedical (U.S.), AccuBioTech Co., Ltd. (China), BD (U.S.), Chembio Diagnostics, Inc. (U.S.), Danaher Corporation (U.S.), EKF DIAGNOSTICS HOLDINGS PLC (U.K.), Johnson & Johnson Services, Inc. (U.S.), QuidelOrtho Corporation. (U.S.), Siemens (Germany), Trinity Biotech Ireland (Ireland), MedMira Inc (Canada).
